Analyses of single extracellular vesicles from non-small lung cancer cells to reveal effects by Epidermal growth factor inhibitor treatments
F. Stridfeldt, S. Cavallaro, P. Haag, R. Lewensohn, J. Linnros, K. Viktorsson, A. Dev
This paper uses single extracellular vesicle analysis to show that osimertinib treatment increases PD-L1, EGFR, and HER2 positive EVs in EGFR-mutant NSCLC cells, while erlotinib does not, suggesting EVs as potential biomarkers for treatment response.
bioRxiv · Oct 14, 2022Bioengineering